Comparative Impact of an Optimized PK/PD Target Attainment of Piperacillin-Tazobactam vs. Meropenem on the Trend over Time of SOFA Score and Inflammatory Biomarkers in Critically Ill Patients Receiving Continuous Infusion Monotherapy for Treating Documented Gram-Negative BSIs and/or VAP
- Resource Type
- Article
- Source
- Antibiotics (2079-6382); Apr2024, Vol. 13 Issue 4, p296, 16p
- Subject
CRITICALLY ill GRAM-negative bacteria MEROPENEM SOFAS MEDIAN (Mathematics) - Language
- ISSN
- 20796382